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Abstract
Objectives: To study the severity of symptoms and estimate the prevalence of oral mucosal lesions in a non-referral 
adult Swedish population, as registered by general dental practitioners. This study also aims to evaluate the possibi-
lity of dental practitioners collecting large quantities of reliable and accurate clinical data on oral mucosal lesions.
Study Design: Data from 6,448 adult Swedish patients were collected by general dental practitioners using a 
standardized registration method. A correlation analysis between a group with oral mucosal lesions and a control 
group, with no oral mucosal lesions, was performed for various parameters such as symptoms from the oral muco-
sa, systemic diseases, medication, allergy history, tobacco habits and the patient’s own assessment of their general 
health. In addition, clinical photos were taken of all oral mucosal lesions in order to determine the degree of agree-
ment between the diagnoses made by general dental practitioners and those made by oral medicine specialists.
Results: A total of 950 patients (14.7%) presented with some type of oral mucosal lesion and of these, 141 patients 
(14.8%) reported subjective symptoms. On a visual analogue scale, 43 patients (4.5%) scored their symptoms <30, 
65 patients (6.8%) scored their symptoms ≥30, and 28 patients (2.6%) scored their symptoms ≥60. The most de-
bilitating condition was aphthous stomatitis and the most common oral mucosal lesion was snuff dipper’s lesion 
(4.8%), followed by lichenoid lesions (2.4%) and geographic tongue (2.2%). There was agreement between the 
oral medicine specialists and the general practitioners over the diagnosis of oral mucosal lesions on the basis of a 
clinical photograph in 85% of the cases (n=803).
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Conclusions: Nearly 15% of the patients with oral mucosal lesions reported symptoms. General practitioners could 
contribute significantly to the collection of large quantities of reliable and accurate clinical data, although there is a 
risk that the prevalence of oral mucosal lesions may be underestimated.
Key words: Epidemiology, oral mucosal lesions, oral medicine, examiner reliability.
Introduction
The morbidity rate for oral mucosal lesions (OML) in 
the general population has not been thoroughly stud-
ied. Several OML are debilitating for patients and may 
also predispose to the development of life-threatening 
disorders. Although the morbidity rate for potentially 
malignant oral diseases has previously received some 
attention, little is known about the extent to which other 
lesions may represent a burden to society.
Patients’ own perceptions of their oral conditions are 
rarely assessed in epidemiological studies of OML. Stud-
ies of the impact of OML upon the Quality of Life (QoL) 
(1-3) have shown that patients are physically, socially and 
psychologically affected, and these effects tend to be un-
derestimated by healthcare providers. It is therefore im-
portant to report the extent to which people suffer from 
symptoms and discomfort in the oral cavity.
Epidemiological data of OML derives mainly from lesion-
specific studies that have been conducted on targeted or 
high-risk populations (4-11). A few studies have used ran-
dom sampling methods in various geographical areas to 
identify the prevalence of OML in the general population 
(12-17). In these studies healthcare providers with a vari-
ety of professional backgrounds have performed the exa-
minations of the oral mucosa, but the accuracy of such 
examinations has not been thoroughly assessed. Only a 
few reports have described in detail how the training of 
the practitioner was performed and evaluated.
It is therefore of interest to evaluate the accuracy of the 
registration by general dental practitioners (GP) of clin-
ical information for large populations. New information 
technology makes it easier to involve GP in academic 
work of this kind and if their contributions are reliable, 
this could enable the expedient collection of extensive 
quantities of epidemiological data.
The aims were 1) to study the severity of subjective 
symptoms caused by OML and to assess the extent to 
which OML are a burden to society, 2) to estimate the 
prevalence of OML in a non-referral adult Swedish po-
pulation, as registered by GP, and 3) to identify possible 
correlations between OML and general health.
Material and Methods
-Patients
A total of 6,448 subjects, who visited their dentist be-
tween 2004 and 2006 for their annual examination, 
were invited to participate in the study. Of these, only 
one refused to participate because of dental fear. The 
patients were examined by one of six GP in six private 
dental clinics in Borås, a medium-sized town of 66,000 
inhabitants in the Southwest of Sweden.
-Data collection
Prior to the study, all the participating dentists undertook 
training by an oral medicine specialist (MJ) in the diag-
nosis of OML, data collection and intraoral photographic 
techniques. The same electronic form, which was deve-
loped in MedView, was used to collect the clinical data in 
all cases. MedView is a computer system for the formal-
ized registration and subsequent analysis of clinical and 
image-based information (18). It operates with an input 
application that is focused on the collection and com-
puterised storage of clinical data. At the first examina-
tion, the medical history of each patient was recorded in 
MedView. The GP were asked to take clinical images of 
all mucosal lesions and all were equipped with the same 
type of camera (Sony Handycam 3 CCD). The result-
ing information was gathered in a single database and 
exported to MedVisualizer. This application is used for 
visualization and scanning of the information that is ob-
tained from the database (18). Finally, the data selected 
for evaluation were transferred to Microsoft Excel for 
Mac 2011 for subsequent statistical analysis.
-Clinical information
The diagnostic labels and criteria for OML were in ac-
cordance with WHO, ICD-DA and with the modifica-
tions and complementary additions suggested by Axéll 
(12,19) and Axéll et al. (20). Systemic diseases were 
registered according to the International Classification 
for Diseases and Health Related Problems, 10th revi-
sion (ICD-10). Allergies reported by the patients were 
grouped into five different categories: “allergic to food 
substances”, “allergic to pollen/grass”, “allergic to ani-
mals”, “allergic to metals/chemicals” and “allergic to bee 
sting”. Smoking habits were grouped into the categories 
“non-smoker”, “1-9 cigarettes per day” and “10 or more 
cigarettes per day”. The patients’ own assessments of 
their health were registered as “healthy” or “unhealthy”. 
Drugs were classified according to the ATC code and the 
Swedish Medicines Compendium for Physicians (FASS). 
In cases in which a single chemical substance belonged 
to two or more ATC codes, the code for a systemic route 
of administration was selected over topical administra-
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tion. A visual analogue scale (VAS) was used to register 
symptoms from the oral mucosa. For statistical purposes, 
the scores were divided into four groups: “no symptoms”, 
“VAS <30”, “VAS ≥30”, and “VAS ≥60”.
-Agreement between GP and oral medicine specialists 
in diagnosis
In the cases in which a tentative diagnosis was esta-
blished by GP, the oral medicine specialists (OMS; MJ 
and UM) made their diagnosis from the corresponding 
clinical photos. The diagnoses made by the GP were 
then compared with those made by the OMS and the 
level of agreement was determined. The comparison 
was classified as follow: “OMS agreed with the GP”, 
“OMS disagreed with the GP”, and “one of the OMS 
agreed with the GP but disagreed with the other OMS”.
-Statistical analysis
For statistical purposes, a group of 1,029 patients without 
OML was compared to the patients with OML (n=1031). 
The groups were compared for all of the variables re-
gistered during the clinical examination (see above) 
in order to identify associations between the different 
parameters and OML. Moreover, groups of diagnoses 
including 20 patients or more were compared to the 
control group in order to see if there was a correlation 
with any of the registered variables. Possible correlation 
between symptoms that were awarded a VAS score ≥30 
and any of the aforementioned variables was also ex-
plored. Fisher’s exact test was used in the analysis and 
a P-value <0.05 was regarded as statistically significant. 
The statistical analysis was performed using the Statis-
tical Analysis Software version 9.2 (SAS Institute Inc. 
Cary, NC, USA).
Results
-Symptoms, disease history and demographics of the 
study population
A total of 141 patients (14.8%) with OML reported sub-
jective symptoms from the oral mucosa. Of these, 43 
patients (4.5%) scored their symptoms <30, 65 patients 
(6.8%) scored their symptoms ≥30, and 28 patients (2.6%) 
scored their symptoms ≥60 in a VAS. Thirty-three pa-
tients (3.5%) presented with subjective symptoms but no 
score in a VAS was registered. A group of 11 patients 
without any clinically detectable OML also presented 
with subjective symptoms from the oral mucosa.
The groups were not matched for age or sex when OML 
patients were compared with the controls. The OML 
group comprised more women (P<0.05). The control 
group reported more malignant neoplasms than did the 
OML patients (P<0.05). Conversely, OML patients re-
ported more ischemic heart diseases and chronic lower 
respiratory diseases (P<0.05). A statistically significant 
difference was also found for smoking habits, with a 
higher prevalence in the control group (P<0.05). There 
was no statistically significant difference between the 
groups for self-reported illness. Four hundred and se-
venty-six (46%) patients with OML were using at least 
one regular systemic medication at the time of the initial 
examination compared to 452 (44%) in the control group 
(n.s.). Use of regular medication was found more often 
among men than women in both groups, and 53.2% of 
the patients with OML used daily medication compared 
to 61.7% of those in the control group (P<0.01). How-
ever, no statistically significant differences were found 
between OML patients and controls in the medication 
profile according to the 1st level of the ATC code.
The demographics and disease history of the patients 
with six of the most common OML and the controls 
are shown in table 1. In general, patients with aphthous 
ulcers reported more allergies than did the controls 
(P<0.05). Also, the prevalence of geographic tongue 
(P<0.05) and snuff lesions (P<0.001) was significantly 
higher among males than among females. Smoking 
was more common among patients with leukoplakia 
than among the controls, although this difference was 
not statistically significant. Hypertensive diseases were 
more common among patients with lichenoid lesions, 
geographic tongue and snuff lesions than among the 
controls (P<0.05). According to the 1st level of the ATC 
code, patients with lichenoid lesions (P<0.001), geo-
graphic tongue (P<0.01) and fissured tongue (P<0.05) 
registered a higher consumption of cardiovascular drugs 
than did the controls.
-The prevalence of OML
From the total of 6,448 individuals examined, the GP 
registered at least one oral condition in 1,031 patients. 
Of these, 950 (mean age=56.0 years; females n=363), or 
14.7% of the patient population, presented with an OML 
diagnosis according to the classification by Axéll and 
Axéll et al (12,20). In eighty-one patients the GP regis-
tered lesions that could not be categorised according to 
these classifications. The remaining 5,417 patients pre-
sented no OML. Table 2 shows the prevalence of OML 
in the study population and compares the estimates with 
those from the two previous studies conducted in Swe-
den. Snuff dipper’s lesion, lichenoid lesions, geographic 
and fissured tongue, aphthous ulcers and leukoplakia 
were compared with the corresponding diagnoses from 
the two previous epidemiological studies conducted in 
Sweden (Fig. 1). 
Although parafunctional related lesions were among the 
most prevalent OML, they were excluded from the anal-
ysis since some of these lesions, such as impressions on 
the lateral border of the tongue, were not reported in the 
studies by Axéll and Salonen et al (12,31).
-Agreement in diagnosis of OML
In 85% of the cases (n=803) the OMS and GP were in 
agreement over the diagnosis, in 14% there was disa-
greement between the OMS and the GP, and in 1% 
there was disagreement between the OMS. The level 
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Aphthous 
ulcers 
 
Parafunctional 
related lesion 
 
Geographic + 
fissured tongue 
Leukoplakia Lichenoid 
lesions 
Snuff dipper's 
lesions 
 
Controls 
Number of patients 34 80 202 24 157 307 1029 
Age (years)  
     Mean ± SD 50.3 ± 16.2 49.5 ± 13.1 61.5 ± 14.6 53.1 ± 13.3 61.91 ± 12.3 46.3 ± 11.0 55.2 ± 15.3 
     Median (range) 47 (23-90) 48 (23-83) 62 (22-93) 52.5 (30-93) 61.9 (31-88) 46 (22-85) 56 (21-92) 
Female (%) 15 (44.1) 46 (57.5) 89 (44.1) 13 (54.2) 84 (53.5) 13 (4.2) 615 (59.8) 
Daily medication (%) 15 (44.1) 36 (45.0) 104 (51.5) 9 (37.5) 91 (58.0) 83 (27.0) 452 (43.9) 
     Among females (%) 9 (26.5) 25 (31.3) 51 (25.2) 7 (29.2) 58 (36.9) 6 (2.0) 279 (27.1) 
     Among males (%) 6 (17.6) 11 (13.8) 54 (26.7) 2 (8.3) 33 (21.0) 77 (25.1) 173 (16.8) 
Allergies (%) 15 (44.1) 24 (30.0) 53 (26.2) 5 (20.8) 39 (24.8) 85 (27.7) 282 (27.4) 
     Food 2 (5.9) 12 (15.0) 18 (8.9) 1 (4.2) 9 (5.7) 16 (5.2) 60 (5.8) 
     Pollen/Grass 7 (20.6) 9 (11.3) 16 (7.9) 4 (16.7) 11 (7.0) 49 (16.0) 113 (11.0) 
     Animals 3 (8.8) 11 (13.8) 16 (7.9) 1 (4.2) 11 (7.0) 25 (8.1) 82 (8.0) 
     Metals/Chemicals 6 (17.6) 10 (12.5) 20 (9.9) 1 (4.2) 15 (9.6) 22 (7.2) 94 (9.1) 
     Bee sting 0 (0.0) 2 (2.5) 0 (0.0) 0 (0.0) 2 (1.3) 2 (0.7) 3 (0.3) 
Smoking habits (%) 1 (2.9) 11 (13.8) 15 (7.4) 7 (29.2) 27 (17.2) 26 (8.5) 158 (15.4) 
     1-9 cigarettes/day 1 (2.9) 6 (7.5) 8 (4.0) 0 (0.0) 17 (10.8) 21 (6.8) 78 (7.6) 
     ?10 cigarettes/day 0 (0.0) 5 (6.3) 7 (3.5) 7 (29.2) 10 (6.4) 5 (1.6) 80 (7.8) 
Presence of symptoms  13 (38.2) 5 (6.3) 23 (11.4) 1 (4.2) 31 (19.7) 16 (5.2) 0 (0.0) 
No VAS score 4 (11.8) 1 (1.3) 8 (4.0) 0 (0.0) 7 (4.5) 4 (1.3) 0 (0.0) 
VAS score <30 2 (5.9) 4 (5.0) 10 (5.0) 1 (4.2) 8 (5.1) 5 (1.6) 0 (0.0) 
VAS score ?30 7 (20.6) 0 (0.0) 5 (2.5) 0 (0.0) 16 (10.2) 7 (2.3) 0 (0.0) 
VAS score ?60 2 (5.9) 0 (0.0) 4 (2.0) 0 (0.0) 4 (2.5) 5 (1.6) 0 (0.0) 
Self-reported illness (%) 13 (38.2) 8 (10.0) 39 (19.3) 4 (16.7) 28 (17.8) 9 (2.9) 132 (12.8) 
?
Table 1. Demographics and medical history of common oral mucosal lesions and controls.
of agreement between the OMS and GP for the twelve 
most common OML diagnoses is shown in table 3. The 
highest rate of agreement between OMS and GP was 
found for geographic tongue, followed by snuff lesions 
and fissured tongue. By contrast, herpes lesion was the 
diagnosis that GP most frequently misdiagnosed. The 
OMS were also able to establish a diagnosis in 118 cases 
where GP had made no diagnosis.
Discussion
The main objective of this study was to investigate 
the extent to which oral conditions are responsible for 
pain or discomfort in the general population. No ear-
lier population study has gathered information about 
subjective symptoms and this is surprising since as-
sessment of QoL represents one of the most important 
ways of evaluating health (3). Many OML are chronic 
in nature and they may have a significant impact on the 
patient’s QoL, not only in terms of physical function-
ing but also in terms of their psychological and social 
effects (2).
A recent study found a good correlation between two 
QoL instruments (COMDQ and OHIP-14) and VAS (1). 
One per cent of our patients reported a VAS ≥30, and 
if this is extrapolated to the whole Swedish population 
over 20 years of age, this would mean that approximate-
ly 70,000 individuals in Sweden are suffering from sig-
nificant discomfort from the oral mucosa. As might be 
expected, the lesions that may involve ulcerations, such 
as aphthous stomatitis and lichenoid reactions, were 
given the highest VAS scores.
Several studies have reported the prevalence of OML 
(12-17,21-27), but there are differences in how registra-
tion of OML was carried out. Several studies have fo-
cused on specific lesions that may be associated with, 
for example, an increased risk of cancer or on lesions 
associated with tobacco or betel use (15,21,25). Some 
studies describe the prevalence in the entire adult popu-
lation (12,14,17,21,23-27), whereas others have selected 
people aged 65 and over (13) or in two specified age 
cohorts (15,16). The selection of a particular age group 
may skew prevalence figures since some lesions are 
more prevalent in certain age groups. Furthermore, 
some types of lesions are rare and a large study po-
pulation is therefore required in order to include them. 
Consequently, any prevalence figure based on a small 
sample must be interpreted with caution. There are only 
four studies that have included more than 10,000 indi-
viduals (12,17,25,26). The remaining studies have in-
cluded populations ranging from 555 (22) to 4,210 (24) 
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?Present Study Axéll Study Salonen Study 
Diagnosis
Total Total Total 
n % % % 
Infections
Angular cheilitis 5 <0.1 3.8 2.4 
Candidiasis 3 <0.1 0.6 0.5 
Herpes zoster 1 <0.1 <0.1 0.1 
Herpes labialis 16 0.2 3.1 0.6 
Intraoral herpes 1 <0.1 0.3 0.3 
Ulcers 
Aphthous ulcer 34 0.5 2.0 1.9 
Traumatic ulcer 7 0.1 4.3 8.0 
Whitish lesions 
Leukoplakia 24 0.4 3.6 1.9 
Lichenoid lesions 157 2.4 1.9 2.4 
Snuff dipper's 
lesion
307 4.8 8.0 7.2 
Smoker's palate 3 <0.1 1.1 3.1 
Cheek and lip 
biting
52 0.8 5.1 2.6 
Tongue lesions 
Geographic
tongue 
141 2.2 8.5 5.6 
Coated tongue 3 <0.1 1.9 1.6 
Hairy tongue 5 <0.1 0.6 0.5 
Fissured tongue 70 1.1 6.5 3.8 
Parafunctional
related changes 
37 0.6 - - 
Atrophic tongue, 
unspecified 
1 <0.1 0.8 0.5 
Vascular lesions 
Varicose veins 6 0.1 - - 
Hematoma 2 <0.1 - - 
Petechiae 2 <0.1 - - 
Pigmentations 
Amalgam tattoo 84 1.3 8.2 6.3 
Excessive melanin 
pigmentation
9 0.1 9.9 6.6 
Denture related 
lesions 
Denture 
stomatitis
7 0.1 16.0 12.5 
Tumours and 
tumour-like lesions 
Fibroepithelial 
polyp 
19 0.3 3.3 9.3 
Gingival
fibromatosis
5 <0.1 0.2 2.3 
Haemangioma 24 0.4 0.1 2.8 
Lipoma 2 <0.1 - - 
Mucocele 3 <0.1 0.1 0.2 
Papilloma 3 <0.1 0.1 0.3 
Table 2. Prevalence of oral mucosal lesions in 6448 Swedish adult 
patients.
?
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Fig. 1. Prevalence of common oral mucosal lesions in the present and previous studies in Sweden.
individuals. The present study population is therefore 
the fifth largest reported. To conclude, the methodologi-
cal differences between studies are considerable, such 
as patient selection and diagnostic criteria for OML, 
and this makes direct comparison difficult. 
Despite the relatively high number of patients in our 
study, several diagnoses were not detected. For exam-
ple, no case of oral cancer was found. This is reasonable 
given the annual incidence of squamous cell carcinoma 
in the Swedish population (approximately 600 cases in 
a population of 9 million). Moreover, our study found 
no cases of vesiculo-bullous conditions (mucous mem-
brane pemphigoid, pemphigus). This is in accordance 
with the large population studies conducted by Shulman 
(17) and Axéll (12), in which none of these diagnoses 
were found, although “desquamative gingivitis” is de-
scribed by Axéll in 3 cases. The absence of vesiculo-
bullous lesions may be attributed partly to its low preva-
lence but partly also to the fact that diagnoses of these 
conditions are usually confirmed by histopathological 
examination. There are unquestionably also other OML 
for which a definitive diagnosis requires support from 
histopathological examination. No biopsies were tak-
en in our study and this is clearly a limitation. How-
ever, this is also true of most of the large prevalence 
studies. Biopsies were only performed in four studies 
(12,14,26,27) and then mainly on lesions that were sus-
pected of malignancy.
Statistical analysis of the demographics and medical 
history (Table 1) was only performed when a diagnosis 
was registered for more than 20 patients, since it was 
considered statistically irrelevant to analyse diagnoses 
that were made for fewer patients. Amalgam tattoo and 
haemangioma were excluded from the analysis, since 
no correlation with medical conditions was expected. 
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?
Agreement between OM experts 
and GP 
Disagreement between OM 
experts and GP 
Disagreement between OM 
experts 
Diagnosis n % n % n % 
Aphthous ulcer 20 83.3 4 16.7 0 0.0 
Amalgam tattoo 60 93.7 3 4.7 1 1.6 
Angioma 13 65.0 7 35.0 0 0.0 
Parafunctional related 
lesion
46 76.7 13 21.7 1 1.7 
Hyperplasia 12 80.0 3 20.0 0 0.0 
Fissured tongue 56 94.9 3 5.1 0 0.0 
Herpes lesions 8 53.3 7 46.7 0 0.0 
Leukoplakia 11 73.3 4 26.7 0 0.0 
Lichenoid lesions 90 80.3 19 17.0 3 2.7 
Geographic tongue 119 96.0 5 4.0 0 0.0 
Snuff dipper’s lesions 185 95.9 8 4.1 0 0.0 
Total 612 89.2 69 10.1 5 0.7 
Table 3. Agreement between general practitioners and oral medicine specialists in the diagnosis of oral mucosal lesions. 
Relationships between specific OML, including condi-
tions such as aphthous stomatitis, oral lichen planus, 
erythema multiforme and orofacial granulomatosis, 
and certain general diseases/drugs have often been 
examined. By contrast, information about medical his-
tory is seldom described in prevalence studies of OML. 
Demographic data and use of drugs were registered by 
Axéll but they were not presented or discussed in terms 
of their correlation with specific OML. Mumcu et al. 
(23) recorded “systemic diseases” and “medication use” 
but no details were provided. The continuous registra-
tion of formalized information in our computerised sys-
tem, MedView, enables such analyses. To the best of 
our knowledge, we are the first to correlate medical data 
with a wide variety of OML. Although no significant 
correlations were found in this study, the potential be-
nefits of being able to analyse such correlations should 
be emphasized.
Crucial to any epidemiological study is the reliability 
of its data, regarding both the general medical infor-
mation and the registered diagnoses. In our study the 
general medical information was obtained through in-
terviews performed by the GP. Also of importance is 
the reliability of registered OML diagnoses. Some stud-
ies assess prevalence according to data obtained from 
examinations by specialists (12-14,22,27). Other stud-
ies have been conducted by GP in order to collect large 
quantities of data in less time (15-17,21,24-26). Most 
studies have included training and calibration in order 
to enhance the quality of registrations. However, only 
a few studies have included analysis of the degree of 
agreement between observers and specialists (15,16,27), 
although this is advisable for ensuring the quality of ob-
tained results. We also found that agreement between 
the GP’ and OMS’ diagnoses varied depending on the 
type of condition and this suggests that reliability was 
higher for some diagnoses than for others. Finally, the 
OMS detected some lesions in images where GP did not 
register any OML. This may be explained either by the 
fact that the GP had noted a lesion but been unable to 
make a diagnosis or that some lesions were simply over-
looked on clinical examination.
When comparing our results with those of previous 
studies it seems reasonable to compare them to the 
Swedish population studies by Axéll (12) and Salonen et 
al. (27). Both of these studies were performed by expe-
rienced specialists and agreement between the findings 
of each was substantial. There are clearly major differ-
ences between the prevalence figures found in the two 
previous Swedish population studies and those found in 
ours. Generally our prevalence rates are lower, which 
may be explained by differences in methodology and 
the fact that the disease panorama has changed. Axéll’s 
and Salonen’s studies have considerable methodological 
similarities since one of the authors participated in both 
studies. In the present study, GP may have under-report-
ed if they only registered the more accentuated lesions. 
For example, no snuff-related lesions were observed by 
the GP in 47 patients who used three or more packs of 
snuff per week, although it is highly unlikely that these 
patients had a completely healthy oral mucosa. It is pos-
sible that an oral medicine expert would have found a 
snuff dipper’s lesion. 
If the percentage distribution of the five most frequently 
reported changes is analysed, Salonen’s distribution 
falls between Axéll’s and that of the present study. The 
lower prevalence of snuff-related lesions and leukopla-
kia makes sense since it corresponds with consumption 
changes over time. In Sweden for the period 1990-2007, 
the prevalence of smoking decreased among men from 
26% to 16% and among women from 27% to 18% (28). 
The use of snuff increased among men from 20% to 
28.6% and among women from 1.4% to 8.4% (28). The 
prevalence of lichenoid lesions remained roughly the-
Med Oral Patol Oral Cir Bucal. 2013 Sep 1;18 (5):e766-72.                                                                                                                               Oral mucosal lesions in an adult Swedish population
e772
same in all three studies and this may be explained by 
the fact that the prevalence of lichenoid lesions has not 
changed significantly over time.
The analysis of the correlation between diagnoses made 
by the GP and those made by the OMS showed that previ-
ously trained GP could contribute significantly to the col-
lection of large quantities of reliable and accurate clinical 
data that could be used for epidemiological analysis in 
the oral medicine field. However, it should be stressed 
that although the GP were trained prior to the start of this 
study, as Splieth et al. (24) described, GP should ideally 
receive continuous training and be monitored throughout 
the entire study to optimize reliability.
References 
1. Riordain RN, McCreary C. The use of quality of life measures in 
oral medicine: A review of the literature. Oral Dis. 2010;16:419-30.
2. Riordain RN, McCreary C. Validity and reliability of a newly de-
veloped quality of life questionnaire for patients with chronic oral 
mucosal diseases. J Oral Pathol Med. 2011;40:604-9.
3. Riordain RN, Meaney S, McCreary C. Impact of chronic oral mu-
cosal disease on daily life: Preliminary observations from a qualita-
tive study. Oral Dis. 2011;17:265-9.
4. Murti PR, Daftary DK, Bhonsle RB, Gupta PC, Mehta FS, Pind-
borg JJ. Malignant potential of oral lichen planus: Observations in 
722 patients from india. J Oral Pathol. 1986;15:71-7.
5. Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K, War-
nakulasuriya S. Incidence rates for oral leukoplakia and lichen pla-
nus in a japanese population. J Oral Pathol Med. 2005;34:532-9.
6. Pindborg JJ, Bhatt M, Devanath KR, Narayana HR, Ramachan-
dra S. Frequency of oral white lesions among 10,000 individuals 
in gangalore, south india. A preliminary report. Indian J Med Sci. 
1966;20:349-52.
7. Pindborg JJ, Chawla TN, Misra RK, Nagpaul RK, Gupta VK. Fre-
quency of oral carcinoma, leukoplakia, leukokeratosis, leukoedema, 
submucous fibrosis, and lichen planus in 10,000 indians in lucknow, 
uttar pradesh, india; preliminary report. J Dent Res. 1965;44:61.
8. Pindborg JJ, Kalapessi HK, Kale SA, Singh B, Talyerkhan BN. Fre-
quency of oral leukoplakias and related conditions among 10,000 bom-
bayites. Preliminary report. J All India Dent Assoc. 1965;37:228-9.
9. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and 
histologic study of oral cancer and leukoplakia among 50,915 villa-
gers in india. Cancer. 1969;24:832-49. 
10. Mehta FS, Gupta PC, Daftary DK, Pindborg JJ, Choksi SK. 
An epidemiologic study of oral cancer and precancerous condi-
tions among 101,761 villagers in maharashtra, india. Int J Cancer. 
1972;10:134-41.
11. Pindborg JJ, Mehta FS, Daftary DK, Gupta PC, Bhonsle RB. Pre-
valence of oral lichen planus among 7639 indian villagers in kerala, 
south india. Acta Derm Venereol. 1972;52:216-20.
12. Axell T. A prevalence study of oral mucosal lesions in an adult 
swedish population. Odontol Revy Suppl. 1976;36:1-103.
13. Espinoza I, Rojas R, Aranda W, Gamonal J. Prevalence of oral 
mucosal lesions in elderly people in santiago, chile. J Oral Pathol 
Med. 2003;32:571-5.
14. Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Mar-
tin JM, Gonzalez Garcia M. Risk factors for oral soft tissue lesions 
in an adult spanish population. Community Dent Oral Epidemiol. 
2002;30:277-85.
15. Lin HC, Corbet EF, Lo EC. Oral mucosal lesions in adult chinese. 
J Dent Res. 2001;80:1486-90.
16. Reichart PA. Oral mucosal lesions in a representative cross-
sectional study of aging germans. Community Dent Oral Epidemiol. 
2000;28:390-8.
17. Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of 
oral mucosal lesions in u.S. Adults: Data from the third national 
health and nutrition examination survey, 1988-1994. J Am Dent As-
soc. 2004;135:1279-86.
18. Jontell M, Mattsson U, Torgersson O. Medview: An instrument 
for clinical research and education in oral medicine. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod. 2005;99:55-63.
19. Axell T. Occurrence of leukoplakia and some other oral white 
lesions among 20,333 adult swedish people. Community Dent Oral 
Epidemiol. 1987;15:46-51.
20. Axell T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M. Inter-
national seminar on oral leukoplakia and associated lesions related to 
tobacco habits. Community Dent Oral Epidemiol. 1984;12:145-54.
21. Ikeda N, Handa Y, Khim SP, Durward C, Axell T, Mizuno T, et 
al. Prevalence study of oral mucosal lesions in a selected cambodian 
population. Community Dent Oral Epidemiol. 1995;23:49-54.
22. Kovac-Kovacic M, Skaleric U. The prevalence of oral mucosal 
lesions in a population in ljubljana, slovenia. J Oral Pathol Med. 
2000;29:331-5. 
23. Mumcu G, Cimilli H, Sur H, Hayran O, Atalay T. Prevalence and 
distribution of oral lesions: A cross-sectional study in turkey. Oral 
Dis. 2005;11:81-7.
24. Splieth CH, Sumnig W, Bessel F, John U, Kocher T. Prevalence 
of oral mucosal lesions in a representative population. Quintessence 
Int. 2007;38:23-9.
25. Zain RB, Ikeda N, Razak IA, Axell T, Majid ZA, Gupta PC, et al. 
A national epidemiological survey of oral mucosal lesions in malay-
sia. Community Dent Oral Epidemiol. 1997;25:377-83.
26. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other 
oral keratoses in 23,616 white americans over the age of 35 years. 
Oral Surg Oral Med Oral Pathol. 1986;61:373-81. 
27. Salonen L, Axell T, Hellden L. Occurrence of oral mucosal lesions, 
the influence of tobacco habits and an estimate of treatment time in 
an adult swedish population. J Oral Pathol Med 1990;19:170-6.
28. Lundqvist G. Tobaksvanor i medelåldern riskfaktormönster, 
rökstoppsattityder och erfarenheter av att sluta röka. Doctoral thesis; 
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